Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures

Stopped early · Phase 3

Conditions studied: Epilepsies, Partial

In brief

This study will determine the safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy subjects for the treatment of partial seizures. The duration of the trial is about 6 months.

Key facts

Study ID

NCT00524030

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

161

Starts

2007-09-01

Expected to finish

2011-06-01

Last updated by the study team

2021-01-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of epilepsy with partial seizures.
• Males or females, age 18 years or older.
• Documented history of at least 4 partial seizures in the 8 weeks prior to the screening visit.
• Stable treatment with 1 to 2 anti-epileptic drugs in the 8 weeks prior to the screening visit.

You may not qualify if…

• Current diagnosis of febrile seizures or seizures related to an ongoing acute medical event.
• Seizures occurring only in cluster patterns, or seizures of a metabolic, toxic or infectious origin.
• Primary generalized epilepsy or status epilepticus within the previous year.

Where it is running

• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Sun City, Arizona, United States
• Pfizer Investigational Site — Fayetteville, Arkansas, United States
• Pfizer Investigational Site — Fullerton, California, United States
• Pfizer Investigational Site — Long Beach, California, United States
• Pfizer Investigational Site — Modesto, California, United States
• Pfizer Investigational Site — Murrieta, California, United States
• Pfizer Investigational Site — Newport Beach, California, United States
• Pfizer Investigational Site — Temecula, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Melbourne, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Sarasota, Florida, United States
• Pfizer Investigational Site — Sarasota, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Decatur, Georgia, United States
• Pfizer Investigational Site — Lawrenceville, Georgia, United States
• Pfizer Investigational Site — Suwanee, Georgia, United States
• Pfizer Investigational Site — Anderson, Indiana, United States
• Pfizer Investigational Site — Danville, Indiana, United States
• Pfizer Investigational Site — Northport, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.